MIRA
INFORM REPORT
|
Report Date : |
08.07.2013 |
IDENTIFICATION DETAILS
|
Name : |
LABORATÓRIO GLOBO LTDA. |
|
|
|
|
Registered Office : |
Rodovia Mg 424, S/Nº, Km 8,8 - Zona Rural, Zip Code 33350-000 - São Jose Da Lapa/Mg |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2012 |
|
|
|
|
Date of Incorporation : |
18.01.1954 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturer of pharmaceuticals. |
|
|
|
|
No. of Employees : |
384 employees |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Brazil |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
brazil ECONOMIC OVERVIEW
Characterized by
large and well-developed agricultural, mining, manufacturing, and service
sectors, Brazil's economy outweighs that of all other South American countries,
and Brazil is expanding its presence in world markets. Since 2003, Brazil has
steadily improved its macroeconomic stability, building up foreign reserves,
and reducing its debt profile by shifting its debt burden toward real
denominated and domestically held instruments. In 2008, Brazil became a net
external creditor and two ratings agencies awarded investment grade status to
its debt. After strong growth in 2007 and 2008, the onset of the global
financial crisis hit Brazil in 2008. Brazil experienced two quarters of
recession, as global demand for Brazil's commodity-based exports dwindled and
external credit dried up. However, Brazil was one of the first emerging markets
to begin a recovery. In 2010, consumer and investor confidence revived and GDP
growth reached 7.5%, the highest growth rate in the past 25 years. Rising
inflation led the authorities to take measures to cool the economy; these
actions and the deteriorating international economic situation slowed growth to
2.7% in 2011, and 1.3% in 2012. Unemployment is at historic lows and Brazil's
traditionally high level of income inequality has declined for each of the last
14 years. Brazil's historically high interest rates have made it an attractive
destination for foreign investors. Large capital inflows over the past several
years have contributed to the appreciation of the currency, hurting the competitiveness
of Brazilian manufacturing and leading the government to intervene in foreign
exchange markets and raise taxes on some foreign capital inflows. President
Dilma ROUSSEFF has retained the previous administration's commitment to
inflation targeting by the central bank, a floating exchange rate, and fiscal
restraint. In an effort to boost growth, in 2012 the administration implemented
a somewhat more expansionary monetary policy that has failed to stimulate much
growth.
|
Source : CIA |
Company name
LABORATÓRIO GLOBO
LTDA.
Company ADDRESSES
|
MAIN ADDRESS: |
RODOVIA MG 424, S/Nº, KM 8,8 - ZONA RURAL |
|
ZIP CODE/CITY: |
33350-000 - SÃO JOSE DA LAPA/MG |
|
|
|
|
PHONE: |
31 3623-3500 |
|
FAX: |
31 3623-3518 |
|
E-MAIL: |
|
|
WEB SITE: |
|
BRANCHES: |
|
DOES NOT HAVE. |
LEGAL DATA
|
MAIN ACTIVITIES: |
|
MANUFACTURE OF PHARMACEUTICALS. |
|
LEGAL FORM: |
LIMITED
LIABILITY COMPANY |
|
|
|
|
INCORPORATION DATE: |
18/01/1954 |
|
REGISTER DATE: |
29/01/1954 |
|
BALANCE SHEET FILING DATE: |
31/12 |
|
TAX CONTRIBUTOR NUMBER(CNPJ): |
17.115.437/0001-73 |
|
STATE REGISTER: |
763.116599.0091 |
|
|
|
|
SHARE CAPITAL: |
R$ 40.000.032,00 |
|
BOARD OF
DIRECTORS: |
|
|
|
|
|
PAULO MONTEIRO LOPES FILHO |
MANAGING PARTNER |
|
ADRIANA LACERDA GARCIA |
MANAGING PARTNER |
|
ANA PAULA CAMPOS MONTEIRO FONSECA |
MANAGING PARTNER |
|
GEOVANE MAURILIO DA SILVA |
MANAGER |
AUTHORIZED USE OF SIGNATURE
|
THE MANAGERS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY. |
|
SHAREHOLDERS /
PARTNERS: |
|
|
|
|
|
NEUZA CAMPOS MONTEIRO |
25,000% |
|
MARIA LINA GARCIA LACERDA |
25,000% |
|
ANA PAULA CAMPOS MONTEIRO FONSECA |
8,333% |
|
PAULO MONTEIRO LOPES FILHO |
8,333% |
|
VIVIANE CAMPOS MONTEIRO |
8,333% |
|
SILVIA LACERDA GARCIA |
8,333% |
|
ADRIANA LACERDA GARCIA |
8,333% |
|
PAULO HENRIQUE G LACERDA |
8,333% |
|
AFFILIATES / SUBSIDIARIES |
|
|
|
|
|
A SCAN THROUGH
OUTSIDE SOURCES SHOWED THE SUBJECT AND/OR DIRECTORS HAS THE FOLLOWING
UNCONFIRMED HOLDINGS: |
|
|
|
|
|
GALIA FARMACEUTICA LTDA |
|
|
NACIONAL HOSPITATAR LDA |
|
|
AREIAO SANTA LUZIA LTDA ME |
|
COMPANY'S BACKGROUND
|
THE SUBJECT WAS ESTABLISHED AND STARTED ITS
ACTIVITIES ON JANUARY 18, 1954. SINCE ITS FOUNDATION IN 1954 IT OPERATES IN THE
SAME LINE OF BUSINESS AND OPERATES UNDER THE CONTROL OF THE FOUNDER PARTNERS.
THE COMPANY OPERATES WITH THE TRADE NAME LABORATÓRIO
GLOBO. IT HAS GOVERNMENT AUTHORIZATION THROUGH A GOVERNMENT BODY NAMED SUS
SISTEMA ÚNICO DE SAÚDE, ("UNIQUE HEALTHY SISTEM") TO OPERATE AS A
PHARMACEUTICAL LABORATORY. PARTNERS/MANAGERS: MARIA LINA GARCIA LACERDA: BRAZILIAN, MARRIED,
TEACHER, RESIDENTIAL ADDRESS AT RUA GONÇALVES DIAS 2579, AP. 700, ZIP CODE
30140-092, BELO HORIZONTE, MG, HOLDER OF DOCUMENTS CPF: 548.950.146-49 AND RG
M-3.034.100 SSP/MG; PAULO MONTEIRO LOPES FILHO: BRAZILIAN, MARRIED,
ADMINISTRATOR, RESIDENTIAL ADDRESS AT RUA HERCULANO DE FREITAS, 138, APTO
1300, BAIRRO GUTIERREZ, ZIP CODE 30430-120, HOLDER OF DOCUMENTS CPF:
770.996.806-68 AND RG M-3.634.575, SSP/MG; ADRIANA LACERDA GARCIA: BRAZILIAN, MARRIED,
ECONOMIST, RESIDENTIAL ADDRESS AT RUA JOÃO EDMUNDO C. BRANT, 466, APTO 801,
BAIRRO ITAPOÃ, ZIP CODE 31710-200, HOLDER OF DOCUMENTS CPF: 031.157.386-09
AND RG M-7.155.618 SSP/MG; ANA PAULA CAMPOS MONTEIRO FONSECA: BRAZILIAN,
MARRIED, ADMINISTRATOR, RESIDENTIAL ADDRESS AT RUA THOMAZ GONZAGA, 657, APTO
1001, BAIRRO DE LOURDES, ZIP CODE 30180-140, HOLDER OF DOCUMENTS CPF:
747.129.856-15 AND RG M-4.040.115 SSP/MG; NEUZA CAMPOS MONTEIRO: NOT AVAILABLE. VIVIANE CAMPOS MONTEIRO: NOT AVAILABLE. SILVIA LACERDA GARCIA: NOT AVAILABLE. PAULO HENRIQUE G LACERDA: NOT AVAILABLE. FURTHER DETAILS ABOUT THE SUBJECT'S HISTORY ARE SO
FAR NOT KNOWN. |
|
PUBLIC
INFORMATION: |
|
NO DETRIMENTAL FILES WERE FOUND. |
FINANCIAL INFORMATION
|
GENERAL BALANCE SHEETS AS OF 31/12/2012, 31/12/2011 AND 31/12/2010. |
|
( FIGURES ARE IN REAIS ). |
|
ASSETS |
|
|
|
|
CURRENT: |
31/12/2012 |
31/12/2011 |
31/12/2010 |
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS |
1.099.505,33 |
613.967,34 |
2.855.663,20 |
|
CLIENTS |
24.179.288,61 |
25.006.465,72 |
18.507.906,44 |
|
INVENTORY |
18.065.717,40 |
15.436.896,72 |
12.536.893,27 |
|
ADVANCE TO SUPPLIERS |
258.228,76 |
345.510,70 |
777.848,72 |
|
RECOVERABLE TAXES |
642.983,84 |
1.208.952,03 |
109.080,21 |
|
INVESTMENTS |
324.656,08 |
83.056,12 |
|
|
OTHER ADVANCES |
21.453,11 |
22.540,14 |
11.623,76 |
|
OTHER CREDITS |
928.015,93 |
250.772,24 |
|
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL CURRENT ASSETS |
45.519.849,06 |
42.968.161,01 |
34.799.015,60 |
|
LONG-TERM
RECEIVABLES: |
|
|
|
|
|
|
|
|
|
JUDICIAL DEPOSITS |
10.516,46 |
4.808,65 |
6.009,01 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL LONG-TERM RECEIVABLES |
10.516,46 |
4.808,65 |
6.009,01 |
|
FIXED ASSETS: |
|
|
|
|
|
|
|
|
|
FIXED ASSETS |
24.999.242,04 |
26.074.636,20 |
19.673.173,64 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL FIXED ASSETS |
24.999.242,04 |
26.074.636,20 |
19.673.173,64 |
|
|
================ |
================ |
================ |
|
TOTAL ASSETS |
70.529.607,56 |
69.047.605,86 |
54.478.198,25 |
|
LIABILITIES: |
|
|
|
|
CURRENT: |
31/12/2012 |
31/12/2011 |
31/12/2010 |
|
|
|
|
|
|
SUPPLIERS |
3.177.471,86 |
2.897.325,87 |
1.945.552,75 |
|
LOANS AND FINANCING |
3.568.570,32 |
3.527.751,77 |
2.246.695,40 |
|
SOCIAL OBLIGATIONS |
259.379,28 |
251.619,18 |
201.142,70 |
|
TAX LIABILITIES |
461.841,91 |
1.420.892,13 |
793.291,73 |
|
LABOR OBLIGATIONS |
900.910,81 |
906.093,62 |
455.125,12 |
|
ADVANCE FROM CLIENTS |
|
109.364,63 |
277.423,84 |
|
OTHER |
1.399,71 |
|
58,59 |
|
PROVISIONS |
|
|
496.251,30 |
|
INCOME TAX/SOCIAL CONTRIBUTION |
1.824.071,30 |
3.476.794,00 |
|
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL CURRENT LIABILITIES |
10.193.645,19 |
12.589.841,20 |
6.415.541,43 |
|
LONG TERM
LIABILITIES: |
|
|
|
|
|
|
|
|
|
LOANS AND FINANCING |
2.741.493,53 |
3.905.666,82 |
2.484.164,65 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL LONG TERM LIABILITIES |
2.741.493,53 |
3.905.666,82 |
2.484.164,65 |
|
NET EQUITY: |
|
|
|
|
|
|
|
|
|
SHARE CAPITAL |
40.000.032,00 |
5.150.000,00 |
5.150.000,00 |
|
REVALUATION RESERVES |
596.328,76 |
596.328,76 |
596.328,76 |
|
ACCRUED PROFIT (LOSS) |
16.998.108,08 |
46.805.769,08 |
39.832.163,41 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL NET EQUITY |
57.594.468,84 |
52.552.097,84 |
45.578.492,17 |
|
|
================ |
================ |
================ |
|
TOTAL LIABILITIES |
70.529.607,56 |
69.047.605,86 |
54.478.198,25 |
|
PROFIT AND LOSS ACCOUNTS AS OF 31/12/2012, 31/12/2011 AND 31/12/2010. |
|
( FIGURES ARE IN REAIS ). |
|
|
31/12/2012 |
31/12/2011 |
31/12/2010 |
|
|
|
|
|
|
GROSS SALES |
72.027.499,02 |
72.787.616,33 |
61.537.761,86 |
|
(-) TAXES ON SALES |
8.933.615,24 |
9.732.372,62 |
8.196.039,21 |
|
|
---------------- |
---------------- |
---------------- |
|
NET SALES |
63.093.883,78 |
63.055.243,71 |
53.341.722,65 |
|
(-) COST OF SOLD GOODS |
34.853.344,11 |
30.031.671,39 |
26.768.178,43 |
|
|
---------------- |
---------------- |
---------------- |
|
GROSS PROFIT |
28.240.539,67 |
33.023.572,32 |
26.573.544,22 |
|
OPERATING REVENUE (EXPENSE) |
-15.373.138,75 |
-15.155.482,22 |
-12.662.235,45 |
|
FINANCIAL REVENUE(EXPENSE) |
-966.877,88 |
-1.061.816,11 |
-509.277,05 |
|
|
---------------- |
---------------- |
---------------- |
|
OPERATIONAL PROFIT (LOSS) |
11.900.523,04 |
16.806.273,99 |
13.402.031,72 |
|
NON-OPERATING RESULT |
69.449,05 |
15.833,78 |
21.500,00 |
|
CONTRIBUTION/INCOME TAX |
-3.977.601,09 |
-5.709.963,06 |
-2.006.520,80 |
|
|
---------------- |
---------------- |
---------------- |
|
NET PROFIT (LOSS) |
7.992.371,00 |
11.112.144,71 |
11.417.010,92 |
|
MONTHLY SALES |
|||
|
|
2013 |
|
|
|
|
--------------------- |
|
|
|
JANUARY |
R$ 5.898.401,88 |
|
|
|
FEBRUARY |
R$ 4.552.178,78 |
|
|
|
MARCH |
R$ 6.828.086,46 |
|
|
|
APRIL |
R$ 7.120.434,94 |
|
|
|
MAY |
R$ 5.827.833,81 |
|
|
|
JUNE |
|
|
|
|
JULY |
|
|
|
|
AUGUST |
|
|
|
|
SEPTEMBER |
|
|
|
|
OCTOBER |
|
|
|
|
NOVEMBER |
|
|
|
|
DECEMBER |
|
|
|
|
TOTAL |
R$ 30.226.935,87 |
|
|
|
RATIOS: |
31/12/2012 |
31/12/2011 |
31/12/2010 |
|
QUICK
RATIO |
2,69 |
|
2,19 |
|
3,47 |
|
|
CURRENT
RATIO |
4,47 |
|
3,41 |
|
5,42 |
|
|
ACCOUNTS
RECEIVABLE TURNOVER |
2,61 |
TIMES |
2,52 |
TIMES |
2,88 |
TIMES |
|
DAYS'
SALES IN RECEIVABLES |
137,96 |
DAYS |
142,77 |
DAYS |
124,91 |
DAYS |
|
INVENTORY
TURNOVER |
1,93 |
TIMES |
1,95 |
TIMES |
2,14 |
TIMES |
|
ACCOUNTS
PAYABLE PERIOD |
32,82 |
DAYS |
34,73 |
DAYS |
26,17 |
DAYS |
|
RETURN
ON ASSETS |
,89 |
TIMES |
,91 |
TIMES |
,98 |
TIMES |
|
SALES
TURNOVER ON NET EQUITY |
1,10 |
TIMES |
1,20 |
TIMES |
1,17 |
TIMES |
|
NET
WORTH TIE-UP |
,43 |
|
,50 |
|
,43 |
|
|
INDEBTEDNESS |
,22 |
|
,31 |
|
,20 |
|
|
EQUITY
RATIO |
81,66 |
% |
76,11 |
% |
83,66 |
% |
|
WORKING
CAPITAL RATIO |
346,55 |
% |
241,29 |
% |
442,42 |
% |
|
GENERAL
SOLVENCY |
5,45 |
|
4,19 |
|
6,12 |
|
|
RETURN
ON NET EQUITY |
13,88 |
% |
21,15 |
% |
25,05 |
% |
|
RETURN
ON SALES (PROFIT MARGIN) |
12,67 |
% |
17,62 |
% |
21,40 |
% |
|
GROSS
PROFIT MARGIN |
44,76 |
% |
52,37 |
% |
49,82 |
% |
|
OPERATIONAL
RESULT |
18,86 |
% |
26,65 |
% |
25,12 |
% |
|
SALES
TURNOVER ON LIABILITIES |
6,19 |
TIMES |
5,01 |
TIMES |
8,31 |
TIMES |
|
FOREIGN
CURRENCY ON ASSETS |
|
|
|
|
|
|
|
FOREIGN
CURRENCY ON LIABILITIES |
|
|
|
|
|
|
|
EXCHANGE RATE: |
|
|
US$ 1,00 = R$ 2,26 |
- OFFICIAL RATE ON 03/07/2013 |
|
US$ 1,00 = R$ 2,04 |
- OFFICIAL RATE ON
31/12/2012 |
|
US$ 1,00 = R$ 1,87 |
- OFFICIAL RATE
ON 31/12/2011 |
|
US$ 1,00 = R$ 1,66 |
- OFFICIAL RATE ON 31/12/2010 |
|
COMMENTS ON THE
FINANCIAL INFORMATION: |
|
FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS. THE FIGURES AVAILABLE SHOW A NORMAL FINANCIAL STANDING. IT
SHOWS HIGH LIQUIDITY RATIOS WITH POSITIVE WORKING CAPITAL AMOUNT AND LOW
LEVEL OF INDEBTEDNESS. IN ADDITION IT IS NOTED DROP IN SALES BUT PROFIT WAS
MADE. |
REAL ESTATE
OWNED PREMISES ARE VALUED AT R$ 8.496.529,95
DETAIL OF OWNED REAL ESTATE
PARTNER
|
TYPE: |
OTHERS |
|
VALUE: |
R$ ,00 |
|
REMARKS: |
THE COMPANY OWNS BUILDINGS VALUED AT R$ 4.912.452,75 AND
LANDS VALUED AT R$ 72.640,00. |
vehicles
OWNED VEHICLES ARE VALUED AT R$ 177.532,71
MACHINES
OWNED MACHINES AND EQUIPMENTS ARE VALUED AT R$ 20.715.678,63
INSURANCE
|
INSURANCE COMPANY: |
TOKIO MARINE SEGURADORA |
|
COVERAGE: |
FIRE |
|
EXPIRATION: |
07/2013 |
|
VALUE: |
R$ 44.025.000,00 |
BANKING REFERENCES
|
|
BRANCH/PHONE: |
CITY: |
|
BANCO DO BRASIL S/A |
31 3299-7900 |
BELO HORIZONTE/MG |
|
BANCO ITAÚ S/A |
31 3249-3655 |
BELO HORIZONTE/MG |
|
BANCO SANTANDER S/A |
31 3269-6887 |
BELO HORIZONTE/MG |
|
REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION
OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE
ARE UNABLE TO PROVIDE ANY BANKING DETAILS. ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY
HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682
BRAZILIAN CENTRAL BANK"). |
ACTIVITIES COMMENTS
|
MANUFACTURE OF MEDICINES FOR HUMAN USAGE. |
|
IMPORT AND
EXPORT: |
IMPORTS FROM:
|
SWITZERLAND, HONG KONG, GERMANY, ITALY, BRITISH VIRGIN ISLAND, SPAIN,
BELGIUM, DENMARK, INDIA |
EXPORTS TO:
|
BOLIVIA. |
|
MAIN CLIENTS: |
|
|
|
|
|
|
|
DOMESTIC
CLIENTS: |
|
PHONE: |
|
BONIFIK DISTRIB PRODS FARMACÊUTICOS LTDA |
|
13 3232-9262 |
|
CERVOSUL DISTRUB. DE MEDICAMENTOS LTDA |
|
51 3230-4000 |
|
DISTRIB VIANA GOMES LTDA |
|
75 623-6612 |
|
GALINDO REPRESENTAÇÕES LTDA |
|
81 3343-8999 |
|
J.S. CUNHA |
|
93 523-1958 |
|
MOITA GARCÊS DISTRIB. LTDA |
|
92 663-6436 |
|
MULTIMED DISTRIBUIDORA MED. LTDA |
|
47 3334-1818 |
|
N.J.A SOUZA E CIA LTDA |
|
93 523-1958 |
|
UNIÃO COMERCIAL LTDA |
|
91 276-0434 |
|
UNIGARRA DISTRIBUIDORA MED. PERFUMARIA LTDA |
|
21 3757-8556 |
|
STAFF: |
|
|
|
THE COMPANY HAS: 384 EMPLOYEE(S) |
CONCEPT AND FULFILMENT
|
THE SUBJECT IS AN OLD-ESTABLISHED COMPANY, OPERATING SINCE 1954. SO
FAR IT HAS A CLEAR TRADE HISTORY AND NO PAYMENT PROBLEMS ARE NOTED. THE COMPANY HAS TRADE RELATIONS WITH SEVERAL SUPPLIERS IN BRAZIL. THE
SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS
ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED. MOST OF THE SUPPLIERS, WHICH PROVIDED INFORMATION, REPORTED PROMPT
PAYMENTS, THUS THE SUBJECT HAS GOOD TRADE REPUTATION. |
|
MAIN SUPPLIERS: |
|
|
|
|
|
|
|
DOMESTIC
SUPPLIERS: |
|
|
|
AGRO QUIMICA MARINGA S/A |
|
|
|
ANALITICA LTDA |
|
31 3481-2155 |
|
CARTOGRÁFICA FÊNIX LTDA |
|
31 443-5005 |
|
CIEL - CONFIANÇA IMP. E EXP. LTDA |
|
21 3535-9550 |
|
DINALAB COMÉRCIO IMP. E EXP. LTDA |
|
11 5588-9000 |
|
GENIX INDUSTRIA FARMACEUTICA LTDA |
|
62 3316-2222 |
|
GIMBA SUPRIM ESCRIT INFORMAT LTDA |
|
|
|
HOLCIM BRASIL S/A |
|
|
|
PAULU´S GRAF EMBALAGENS LTDA |
|
31 3426-1224 |
|
PB PONTO DO BOMBEIRO MAT HIDR LTDA |
|
|
|
PRINT COMPANY LTDA |
|
31 3488-1455 |
|
SUPERMIX COML S/A |
|
|
|
VALDEQUIMICA PRODUTOS QUÍMICOS LTDA |
|
11 3721-1077 |
|
WHEATON DO BRASIL IND E COM LTDA |
|
11 4351-4433 |
|
FOREIGN
SUPPLIERS: |
COUNTRY: |
PHONE: |
|
AARTHI DRUGS LTD |
INDIA |
022 407 34 62 |
|
ACG PAM PAC MACH PHARMA TECH PVT LTD |
INDIA |
912230780700 |
|
ALLPHARMA RESEARCH S.L. |
SWITZERLAND |
|
|
CADILA HEALTHCARE LIMITED |
INDIA |
(91 79) 2686 8100 |
|
CHEMPHAR |
HONG KONG |
|
|
ERWEKA GMBH |
GERMANY |
(06104) 6903-0 |
|
FARMABIOS SPA |
ITALY |
|
|
FERSINSA GIST-BROCADES S.A DE C.V |
|
|
|
HOMESTEAD INTERNACIONAL COMPANY CO |
BRITISH VIRGIN ISLAN |
|
|
IMPEX QUIMICA |
SPAIN |
|
|
MEDILON E CO N.V |
BELGIUM |
|
|
MEDIPHARM LTD A.S |
DENMARK |
|
|
SELECTCHEMIE AG |
SWITZERLAND |
41(0) 14879611 |
|
SUPOR PHARMACEUTICALS CO. LTD. |
|
|
|
PAYMENT HISTORY: |
|
09 SUPPLIERS REPORTED PAYMENTS: |
|
TOTAL AMOUNT: R$ 150.304,00 |
|
|
|
AMOUNT OF INVOICES PAID: 56 |
|
TOTAL OF PROMPT PAYMENTS: 95,5% |
|
TOTAL OF DELAYED PAYMENTS: 4,5% |
|
|
|
HIGHEST INVOICE: R$ 10.255,00 |
|
HIGHEST CREDIT: R$ 10.255,00 |
|
|
|
OUTSTANDING INVOICES DUE WITHIN THE NEXT 30 DAYS: |
|
--------------------------- |
SUPPLIERS: |
INVOICES: |
TOTAL
AMOUNT: |
|
DUE WITHIN 30 DAYS |
1 |
2 |
R$ 2.356,00 |
FINAL OPINION
|
THE SUBJECT IS A WELL-ESTABLISHED COMPANY IN BUSINESS FOR SEVERAL
YEARS. UP TO DATE IT HAS A GOOD FINANCIAL STANDING, A CLEAR TRADE HISTORY AND
GOOD PAYMENT BEHAVIOUR. BASED ON THE GENERAL INFORMATION
AVAILABLE IT IS BELIEVED THAT GOOD TRADE RELATIONS MAY BE ESTABLISHED. CREDIT
FACILITIES MAY BE EXTENDED WITHIN TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S
FINANCIAL STRENGTH. |
|
|
|
|
|
|
|
|
|
BALANCE SHEET ANALYSIS |
FIGURES ARE IN REAIS |
|
|
|
|
|
|
|
31/12/2012 |
|
31/12/2011 |
|
31/12/2010 |
|
|
ASSETS |
|
% |
|
% |
|
% |
|
Current Assets |
64.54 |
$
42,968,161 |
62.23 |
$
34,799,016 |
63.88 |
|
|
Fixed Assets |
$
24,999,242 |
35.45 |
$
26,074,636 |
37.76 |
$
19,673,174 |
36.11 |
|
TOTAL ASSETS |
$
70,529,608 |
100.00 |
$
69,047,606 |
100.00 |
$
54,478,198 |
100.00 |
|
LIABILITIES |
|
|
|
|
|
|
|
Current Liabilities |
$
10,193,645 |
14.45 |
$
12,589,841 |
18.23 |
$
6,415,541 |
11.78 |
|
Long-Term Liabilities |
$ 2,741,494 |
3.89 |
$ 3,905,667 |
5.66 |
$
2,484,165 |
4.56 |
|
TOTAL LIABILITIES |
$
12,935,139 |
18.34 |
$
16,495,508 |
23.89 |
$
8,899,706 |
16.34 |
|
Deferred Income |
$ - |
0.00 |
$
- |
0.00 |
$ - |
0.00 |
|
Net Equity |
$
57,594,469 |
81.66 |
$
52,552,098 |
76.11 |
$
45,578,492 |
83.66 |
|
TOTAL LIABILITIES + NET EQUITY |
$
70,529,608 |
100.00 |
$
69,047,606 |
100.00 |
$
54,478,198 |
100.00 |
|
PROFIT AND LOSS ACCOUNTS |
|
|
|
|
|
|
|
Net Sales |
$
63,093,884 |
100.00 |
$
63,055,244 |
100.00 |
$
53,341,723 |
100.00 |
|
Costs |
$
34,853,344 |
55.24 |
$
30,031,671 |
47.63 |
$
26,768,178 |
50.18 |
|
Gross Profit |
$
28,240,540 |
44.76 |
$
33,023,572 |
52.37 |
$
26,573,544 |
49.82 |
|
Operating expenses |
$
(15,373,139) |
-24.37 |
$
(15,155,482) |
-24.04 |
$
(12,662,235) |
-23.74 |
|
operational Result |
$
11,900,523 |
18.86 |
$
16,806,274 |
26.65 |
$
13,402,032 |
25.12 |
|
Net Profit (loss) |
$ 7,992,371 |
12.67 |
$
11,112,145 |
17.62 |
$
11,417,011 |
21.40 |
|
COMPLEMENTARY DATA |
|
|
|
|
|
|
|
Inventory |
$
18,065,717 |
|
$
15,436,897 |
|
$
12,536,893 |
|
|
Accounts receivable |
$
24,179,289 |
|
$
25,006,466 |
|
$
18,507,906 |
|
|
Accounts Payable |
$ 3,177,472 |
|
$ 2,897,326 |
|
$
1,945,553 |
|
|
Property, plant and equipment |
$
24,999,242 |
|
$
26,074,636 |
|
$
19,673,174 |
|
|
Purchases |
$
24,999,242 |
|
$
26,074,636 |
|
$
19,673,174 |
|
|
Financial Expenses |
$ (966,878) |
|
$
(1,061,816) |
|
$
(509,277) |
|
|
Foreign Currency Assets |
|
|
|
|
|
|
|
Foreign Currency Liabilities |
|
|
|
|
|
|
|
Working Capital |
$
35,326,204 |
|
$
30,378,320 |
|
$
28,383,474 |
|
|
RATIOS: |
|
|
|
|
|
|
|
QUICK RATIO |
2.69 |
|
2.19 |
|
3.47 |
|
|
CURRENT RATIO |
4.47 |
|
3.41 |
|
5.42 |
|
|
ACCOUNTS RECEIVABLE TURNOVER |
2.61 |
times |
2.52 |
times |
2.88 |
times |
|
DAYS' SALES IN RECEIVABLES |
137.96 |
days |
142.77 |
days |
124.91 |
days |
|
INVENTORY TURNOVER |
1.93 |
times |
1.95 |
times |
2.14 |
times |
|
32.82 |
days |
34.73 |
days |
26.17 |
days |
|
|
RETURN ON ASSETS |
0.89 |
times |
0.91 |
times |
0.98 |
times |
|
SALES TURNOVER ON NET EQUIY |
1.10 |
times |
1.20 |
times |
1.17 |
times |
|
NET WORTH TIE-UP |
0.43 |
|
0.50 |
|
0.43 |
|
|
ENDEBTEDNESS |
0.22 |
|
0.31 |
|
0.20 |
|
|
EQUITY RATIO |
81.66 |
% |
76.11 |
% |
83.66 |
% |
|
WORKING CAPITAL RATIO |
346.55 |
% |
241.29 |
% |
442.42 |
% |
|
GENERAL SOLVENCY |
5.45 |
|
4.19 |
|
6.12 |
|
|
RETURN ON NET EQUITY |
13.88 |
% |
21.15 |
% |
25.05 |
% |
|
RETURN ON SALES (PROFIT MARGIN) |
12.67 |
% |
17.62 |
% |
21.40 |
% |
|
GROSS PROFIT MARGIN |
44.76 |
% |
52.37 |
% |
49.82 |
% |
|
OPERATIONAL RESULT |
18.86 |
% |
26.65 |
% |
25.12 |
% |
|
SALES TURNOVER ON LIABILITIES |
6.19 |
times |
5.01 |
times |
8.31 |
times |
|
FOREIGN CURRENCY ON ASSETS |
- |
% |
- |
% |
- |
% |
|
FOREIGN CURRENCY ON LIABILITIES |
- |
% |
- |
% |
- |
% |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.60.34 |
|
UK Pound |
1 |
Rs.90.79 |
|
Euro |
1 |
Rs.77.81 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any risk
and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its
officials.